Androstenones

Details Androstenones Androstenones

1998-05-14

1999-11-02

Ford, John M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514278, A61K 31435

Patent

active

059771267

ABSTRACT:
The present invention relates to methods for preparing and using compounds of formula (I), wherein carbons 1 and 2 are joined by either a single or a double bond; R.sup.1 is hydrogen or methyl; R.sup.2 is hydrogen or methyl; R.sup.3 is (A) wherein X, W, Z, R.sup.4, and R.sup.5, are various groups, and pharmaceutically acceptable solvates thereof and their use in the treatment of androgen responsive and mediated diseases.

REFERENCES:
patent: 4377584 (1983-03-01), Rasmusson et al.
patent: 4760071 (1988-07-01), Rasmusson et al.
patent: 5017568 (1991-05-01), Holt et al.
patent: 5084574 (1992-01-01), Bhattacharya et al.
patent: 5098908 (1992-03-01), Steinberg et al.
patent: 5215894 (1993-06-01), Arison et al.
patent: 5730964 (1998-03-01), Waldstreicher
Lepor, New Eng. door, Med. vol. 335 No. 6 pp. 533-539, Aug. 1996.
McGinley, et al., New England Journal of Medicine, 300, 1979, pp. 1233-1237.
Robaire, et al., Steroid Biochem., 8, 1977, pp. 307-310.
Petrow, et al., Steroids, 38, 1981, p. 121.
Liang, et al., J. Steroid Biochem., 19, 1983, pp. 385-390.
Holt, et al., J. Med. Chem., 33, 1990, 937-942 "Steroidal A Ring Aryl Carboxylic Acids: A New Class of Steroid 5-Reductase Inhibitors".
Stoner, et al., J. Steroid Biochem. Molec. Biol., vol. 37, 1990, pp. 375-378.
Russell, D.W., et al., J. Clin, Invest., 89, 1992, p. 293.
Russell, D.W., et al., Nature, 354, 1991, p. 159.
Russell, D.W., et al., New England J. of Med., 327, 1992, p. 1216.
Russell, D.W., et al., J. Clin Invest., 90, 1992, p. 799.
Brooks, et al., Steroids, 47, 1986, p.1, "5.alpha.-Reductase Inhibitory and Anti-Androgenic Activities of Some 4-Azasteroids in the Rat".
Rasmusson, et al., J. Med. Chem., 29, 1986, pp. 2298-2315, "Steroids: Structure-Activity Relationships for Inhibition of 5.alpha.-Reductase and Androgen Receptor Binding".
Rasmusson, et al., J. Med. Chem., 27, 1984, pp. 1690-1701, "Azsteroids a Inhibitors of Rat Prostactic 5.alpha.-Reductase".
Imperato, et al., IG, 1986, 130-133, "Inherited 5.alpha.-Reductase Deficiency in Man".
Jones, et al., British J. of Urology, 66, 1990, pp. 506-508, "Origin and Structure of Benign Prostatic Hyperplasia".
Blakitnyi, et al., J. of Organic Chem., vol. 10, No.3, 1974, pp. 512-516, "Synthesis of the Analogs of 3-p-Menthanol With a Fluorinated Methyl Group."
Reetz, et al., Angew. Chem. Int. Ed. Engl., vol. 19, No. 11, 1980, pp. 900-901, "Geminal Dialkylation of Ketones with Grignard Compounds and Methyltitanium (IV) Chlorides."
Davies, H.W., et al., Tetrahedron Letters, vol. 30, No. 38, 1989, pp. 5057-5060, "Stereoselective Cyclopropanations with Vinylcarbenoids."
Baum, et al., Synthetic Communications, vol. 30, No. 14, 1987, pp. 1709-1716, "Diazotransfer Reactions with p-Acetamidobenzenesulfonyl Azide. "
He, et al., J Med. Chem. 36, 1993, pp. 1188-1193, Synthesis and Biological Evaluation of 1-[1-(2-Benzo[b]thienyl)cyclohexyl]piperidine Homologues at Dopamine-Uptake and Phencyclidine-and .sigma.-Binding Sites.

Affiliated with

Also associated with

Rating

Androstenones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Androstenones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Androstenones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2135820